Literature DB >> 24009052

The impact of the nutritional state of patients on the results of the surgical treatment of ulcerative colitis.

Urszula Skowrońska-Piekarska, Konrad Matysiak, Anna Sowińska.   

Abstract

UNLABELLED: A variety of mechanisms have been proposed to explain the malnutrition and body mass loss in UC patients. The aim of the study trial was a nutritional state assessment of 347 UC patients, admitted for surgical treatment, and the evaluation of the impact of this state on the postoperative course in this group of patients.
MATERIAL AND METHODS: We referred the results of nutritional state assessment to the length of time of postoperative hospitalization of patients.
RESULTS: Through application of the Kruskal-Wallis test we found statistically significant, but weakly expressed, differences between the values of nutritional state parameters and period of hospitalization of patients. The applied U Mann-Whitney test, with statistically significant results with p <0.05, showed statistically significant differences between cured and dead subgroups in: 1) loss of body mass in 6 months before hospitalization (p = 0.000033), 2) hemoglobin level (p = 0.006676), 3) total lymphocyte count (TLC) (p = 0.025242), 4) total serum protein level (p = 0.003485), 5) serum albumin level (p =0.00165). Differences in BMI values were statistically negligible (p = 0.969397).
CONCLUSIONS: The body mass loss in 6 months before admission, total lymphocyte count and serum albumin level are the reference parameters of the nutritional state of UC patients on admission to surgery.

Entities:  

Mesh:

Year:  2013        PMID: 24009052     DOI: 10.2478/pjs-2013-0065

Source DB:  PubMed          Journal:  Pol Przegl Chir        ISSN: 0032-373X


  2 in total

1.  Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort.

Authors:  Geoffrey C Nguyen; Lillian Du; Rachel Y Chong; Timothy D Jackson
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

Review 2.  [Drug treatment of chronic inflammatory bowel diseases-What must the surgeon know and perioperatively pay attention to?]

Authors:  Kathleen Lange; Andreas Stallmach
Journal:  Chirurg       Date:  2021-01       Impact factor: 0.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.